Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation

Published:2018-02-20 Issue:8 Volume:53 Page:1001-1009
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Avivi Irit^ORCID,Boumendil Ariane,Finel Hervé,Nagler Arnon,de Sousa Aïda Botelho,Santasusana Josep Maria Ribera,Vandenberghe Elizabeth,Afanasyev Boris,Bordessoule Dominique,Moraleda José Maria,Garcia Eulogio Conde,Pohlreich David,Garcia Gonzalo Gutiérrez,Thomson Kirsty,Or Reuven,Beelen Dietrich,Zuffa Eliana,Giebel Sebastian,Berthou Christian,Salles Gilles^ORCID,Melpignano Angela,Montoto Silvia,Dreger Peter

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-017-0063-7.pdf

Reference18 articles.

1. Dunleavy K, Wilson WH. Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach? Blood. 2015;125:33–9.

2. Rieger M, Osterborg A, Pettengell R, White D, Gill D, Walewski J, et al. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol. 2011;22:664–70.

3. Martelli M, Ceriani L, Zucca E, Zinzani PL, Ferreri AJ, Vitolo U, et al. 18FFluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the international extranodal lymphoma study group IELSG-26 study. J Clin Oncol. 2014;32:1769–75.

4. Aoki T, Izutsu K, Suzuki R, Nakaseko C, Arima H, Shimadaet K, et al. Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan. Haematologica. 2014;99:1817–25.

5. Vassilakopoulos TP, Pangalis GA, Chatziioannou S, Papageorgiou S, Angelopoulou MK, Galani Z, et al. PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: an analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy. Leukemia. 2016;30:238–42.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study;Leukemia;2024-03-08

2. Updates in the Management of Primary Mediastinal B Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-12

3. High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma;Transplantation and Cellular Therapy;2023-11

4. Relapsed/Refractory Primary Mediastinal B-cell Lymphoma: Where do we Stand?;Transplantation and Cellular Therapy;2023-11

5. Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2022-11